<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03549910</url>
  </required_header>
  <id_info>
    <org_study_id>Huaxi ICU-APRV</org_study_id>
    <nct_id>NCT03549910</nct_id>
  </id_info>
  <brief_title>A Multiple Centre,Random Control Study :Early Use of Airway Pressure Release Ventilation (APRV) Plus Protocol in ARDS</brief_title>
  <official_title>A Multiple Centre,Random Control Study :Early Use of Airway Pressure Release Ventilation Updated (APRV Plus) Protocol in Acute Respiratory Disease Syndrome (ARDS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Animal experimentals have shown that the more physiology-driven airway pressure release
      ventilation (APRV) methodologies in ARDS may significantly improve alveolar recruitment and
      gas exchange, increased homogeneity, and attenuate lung injury, without circulatory
      depression, as compared with conventional low tial volume lung protective ventilation. our
      previous single centre,random control study showed that clinical benefit for early use of
      APRV in ARDS. Nonetheless, clinical data on ARDS are still limited, most of them derived from
      small clinical trials in which variable outdated APRV settings were used, consequently, the
      findings of these studies were controversial.

      Additionally, the previous single-centre,random control study showed that clinical benefit
      for APRV.Therefore,the investigators are ready to design a multiple centres,random control
      study to further verify the effect of APRV plus protocol in ARDS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients included will be randomly assigned to receiving APRV plus protocol or low
      tidal volume ventilation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 20, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>Day 28</time_frame>
    <description>mortality at Day28</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation free days</measure>
    <time_frame>Day 28</time_frame>
    <description>Mechanical ventilation free days at Day28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxygenation</measure>
    <time_frame>from enrollment to Day7</time_frame>
    <description>oxygenation index:PaO2:fiO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>repiratory system compliance</measure>
    <time_frame>from enrollment to Day7</time_frame>
    <description>static repiratory system compliance (ml/cmH2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>during the mechanical ventilation procedure</time_frame>
    <description>mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation depth</measure>
    <time_frame>during the mechanical ventilation procedure</time_frame>
    <description>RASS scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedative drug</measure>
    <time_frame>during the mechanical ventilation procedure</time_frame>
    <description>the total dose of Sedative drug</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>successful extubation rate</measure>
    <time_frame>during the mechanical ventilation procedure</time_frame>
    <description>the rate of successful extubation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>adverse events related to mechanical ventilation</measure>
    <time_frame>during the mechanical ventilation procedure</time_frame>
    <description>including pneumothorax,VAP,and so on</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Early use of APRVplus protocol in ARDS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>physiology-driven APRVplus protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low tidal volume ventilation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Low tidal volume lung protective ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>APRVplus protocol</intervention_name>
    <description>Physiology-driven APRVplus protocol</description>
    <arm_group_label>Early use of APRVplus protocol in ARDS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low tidal volume ventilation</intervention_name>
    <description>Low tidal volume lung protective ventilation</description>
    <arm_group_label>Low tidal volume ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate and severe acute respiratory distress syndrome,according to the Berlin
             definition of ARDS

          -  receiving tracheal intubation and mechanical ventilation was no longer than 48 hours

        Exclusion Criteria:

          -  Pregnancy

          -  The expected duration of mechanical ventilation was less than 48 hours

          -  Intracranial hypertension (suspected or confirmed)

          -  Neuromuscular disorders that are known to prolong the need for mechanical ventilation

          -  Known or suspected chronic obstructive pulmonary disease(COPD)

          -  Terminal stage of disease

          -  Pneumothorax (drained or not)at enrollment

          -  Treatment with extracorporeal support (ECMO) at enrollment

          -  There was a lack of commitment to life support.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kang Yan</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yongfang Zhou</last_name>
    <phone>86 18140212276</phone>
    <email>zyfmg@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yan Kang</last_name>
    <phone>86 18980601566</phone>
    <email>kang_yan_123@163.com</email>
  </overall_contact_backup>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>June 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2018</study_first_posted>
  <last_update_submitted>June 7, 2018</last_update_submitted>
  <last_update_submitted_qc>June 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Kang Yan</investigator_full_name>
    <investigator_title>Director of department of Critical Care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

